Hiroyuki Hanayama Selected Research

Hiroyuki Hanayama Research Topics

Disease

15	Neoplasms (Cancer) 02/2024 - 11/2016
10	Stomach Neoplasms (Stomach Cancer) 01/2024 - 09/2011
9	Esophageal Squamous Cell Carcinoma 02/2024 - 01/2018
5	Neoplasm Metastasis (Metastasis) 01/2024 - 11/2015
3	Bites and Stings (Sting) 02/2024 - 01/2023
1	Abscess 12/2023
1	Brain Neoplasms (Brain Tumor) 12/2023
1	Wounds and Injuries (Trauma) 12/2023
1	Abdominal Abscess 12/2023
1	Inflammation (Inflammations) 01/2023
1	Pneumonia (Pneumonitis) 08/2022
1	Upper Extremity Deep Vein Thrombosis 03/2022
1	Postoperative Hemorrhage 01/2022
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2022
1	Peptic Esophagitis (Reflux Esophagitis) 11/2021
1	Epstein-Barr Virus Infections 11/2021
1	Protein Deficiency 11/2021
1	Circulating Neoplastic Cells 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 10/2020
1	Tuberculous Peritonitis 01/2020
1	Ascites 01/2020
1	Granuloma 01/2020
1	Rectal Neoplasms (Rectal Cancer) 12/2019
1	Peritonitis 12/2019
1	Rectovaginal Fistula 12/2019
1	Anastomotic Leak 12/2019
1	Esophageal Neoplasms (Esophageal Cancer) 12/2018
1	Infections 12/2015

Drug/Important Bio-Agent (IBA)

4	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2018
3	InterferonsIBA 02/2024 - 01/2023
3	cyclic guanosine monophosphate-adenosine monophosphateIBA 02/2024 - 01/2023
3	ChemokinesIBA 02/2024 - 01/2021
3	NivolumabIBA 01/2024 - 07/2023
2	Interferon Type IIBA 02/2024 - 01/2023
2	RamucirumabIBA 12/2023 - 01/2019
2	InterleukinsIBA 10/2023 - 01/2023
2	Biomarkers (Surrogate Marker)IBA 07/2023 - 10/2020
2	CytokinesIBA 01/2023 - 01/2021
2	Cancer VaccinesIBA 08/2018 - 01/2018
1	Fluorouracil (Carac)FDA LinkGeneric 02/2024
1	Cisplatin (Platino)FDA LinkGeneric 02/2024
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2024
1	EpitopesIBA 01/2024
1	AntigensIBA 01/2024
1	Circulating Tumor DNAIBA 01/2024
1	130-nm albumin-bound paclitaxelIBA 12/2023
1	LigandsIBA 10/2023
1	Serum AlbuminIBA 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 11/2021
1	MicroRNAs (MicroRNA)IBA 11/2021
1	Messenger RNA (mRNA)IBA 11/2021
1	PeriostinIBA 06/2021
1	Versicans (Versican)IBA 06/2021
1	LumicanIBA 06/2021
1	Chemotactic FactorsIBA 01/2021
1	trastuzumab deruxtecanIBA 01/2021
1	Macrophage Colony-Stimulating FactorIBA 01/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2021
1	Topoisomerase I InhibitorsIBA 01/2021
1	tributyl phosphate (TBP)IBA 01/2020
1	Estriol (Epiestriol)IBA 12/2019
1	Vaginal Creams, Foams, and Jellies (Vaginal Tablet)IBA 12/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2019
1	B7-H1 AntigenIBA 07/2018
1	Glycogen Synthase KinasesIBA 07/2018
1	acarboxyprothrombin (PIVKA)IBA 11/2016
1	Irinotecan (Camptosar)FDA LinkGeneric 11/2016
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2015
1	Protons (Proton)IBA 11/2015

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 02/2024 - 11/2015
5	Immunotherapy 01/2024 - 01/2018
4	Neoadjuvant Therapy 02/2024 - 12/2018
4	Gastrectomy 01/2023 - 09/2011
4	Lymph Node Excision (Lymph Node Dissection) 12/2019 - 09/2011
3	Therapeutics 01/2024 - 01/2019
2	Radiotherapy 01/2024 - 10/2023
2	Chemoradiotherapy 07/2023 - 12/2018
2	Esophagectomy 08/2022 - 03/2022
2	Adjuvant Chemotherapy 10/2020 - 09/2011
1	Palliative Care (Palliative Therapy) 12/2023
1	Central Venous Catheters 03/2022
1	Operative Surgical Procedures 01/2022
1	Endoscopic Hemostasis 01/2022
1	Laparotomy 12/2019
1	Ileostomy 12/2019
1	Conservative Treatment 12/2019
1	Combination Drug Therapy (Combination Chemotherapy) 01/2019